LANSING (WKZO) -- A lab in Lansing will double its production of an anthrax vaccine. To handle the increase, Maryland-based owner Emergent BioSolutions will open a new facility in the city. Reportedly Emergent has a 1.25-billion dollar deal with the government to provide 45-million doses of the BioThrax vaccine.
Talk Radio Countdown 5:00 AM - 7:00 AM
On Air Now.